Beijing: China will make its COVID-19 vaccine a global public good when it is ready for application after successful research and clinical trials, a senior Chinese official said Sunday to media in China.
The Minister of Science and Technology, Wang Zhigang, said at a press conference in Beijing that international cooperation should be strengthened in vaccine development, clinical trials and application.
Vaccine development should focus on ensuring safety, effectiveness, and accessibility, Wang said.
To date, four inactivated vaccines and one adenovirus vaccine have been approved for clinical trials, said a white paper titled “Fighting COVID-19: China in Action,” which was released by the State Council Information Office on Sunday.
